Literature DB >> 2213076

Spirometric findings and mortality in never-smokers.

P Lange1, J Nyboe, M Appleyard, G Jensen, P Schnohr.   

Abstract

The relation of ventilatory function to overall mortality has been studied in 662 male and 2048 female never-smokers who during the period 1976-1978 participated in the Copenhagen City Heart Study, a prospective community study of more than 14,000 men and women randomly selected from the general population of the City of Copenhagen. Until the end of 1986, 195 subjects who said they were never-smokers died. Mortality was analyzed using the proportional hazards model of Cox. In addition to measures of ventilatory function, the mortality analysis included age, sex, body-mass index, alcohol consumption, school education, diabetes mellitus, heart disease and bronchial asthma as confounding factors. Forced expiratory volume in 1 second (FEV1) as a percentage of that predicted, forced vital capacity (FVC) as a percentage of that predicted and the ratio of FEV1 to FVC were significant risk factors for mortality among both sexes. The relative risk of death associated with a 50% decrease in FEV1 and FVC as a percentage of a predicted value was 1.65 and 1.81, respectively. This study confirms that lowered ventilatory function is a strong risk factor for mortality among never-smokers of both sexes.

Entities:  

Mesh:

Year:  1990        PMID: 2213076     DOI: 10.1016/0895-4356(90)90070-6

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  32 in total

1.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee.

Authors:  Lorcan P McGarvey; Matthias John; Julie A Anderson; Michael Zvarich; Robert A Wise
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

2.  Ventilatory function, height, and mortality among lifelong non-smokers.

Authors:  D P Strachan
Journal:  J Epidemiol Community Health       Date:  1992-02       Impact factor: 3.710

3.  Lung function decline over 25 years of follow-up among black and white adults in the ARIC study cohort.

Authors:  Maria C Mirabelli; John S Preisser; Laura R Loehr; Sunil K Agarwal; R Graham Barr; David J Couper; John L Hankinson; Noorie Hyun; Aaron R Folsom; Stephanie J London
Journal:  Respir Med       Date:  2016-02-11       Impact factor: 3.415

4.  Decline in lung function and mortality: the Busselton Health Study.

Authors:  G Ryan; M W Knuiman; M L Divitini; A James; A W Musk; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  1999-04       Impact factor: 3.710

5.  Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men.

Authors:  M Pelkonen; H Tukiainen; M Tervahauta; I L Notkola; S L Kivelä; Y Salorinne; A Nissinen
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

6.  Best lung function equations for the very elderly selected by survival analysis.

Authors:  Martin R Miller; Mikael Thinggaard; Kaare Christensen; Ole F Pedersen; Torben Sigsgaard
Journal:  Eur Respir J       Date:  2014-01-31       Impact factor: 16.671

7.  Forced vital capacity predicts long-term survival for curative-resected NSCLC.

Authors:  Xi Guo; Hongxin Cao; Jun Xu; Jianyu Yu; Chunlong Zheng; Long Meng; Jiajun Du
Journal:  Med Oncol       Date:  2014-08-07       Impact factor: 3.064

8.  Gender differences in the effect of occupational endotoxin exposure on impaired lung function and death: the Shanghai Textile Worker Study.

Authors:  Peggy S Lai; Jing-Qing Hang; Feng-Ying Zhang; Xinyi Lin; Bu-Yong Zheng; Hei-Lian Dai; Li Su; Tianxi Cai; David C Christiani
Journal:  Occup Environ Med       Date:  2013-12-02       Impact factor: 4.402

9.  Whole-genome analyses of lung function, height and smoking.

Authors:  Luc Janss; Torben Sigsgaard; Daniel Sorensen
Journal:  Ann Hum Genet       Date:  2014-08-01       Impact factor: 1.670

10.  Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study.

Authors:  D Gunnell; E Whitley; M N Upton; A McConnachie; G Davey Smith; G C M Watt
Journal:  J Epidemiol Community Health       Date:  2003-02       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.